A rare homozygous mutation in the YARS2 gene presents with hypertrophic cardiomyopathy, lactic acidosis and anemia in a Chinese infant
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Decompensation of cardiorespiratory function and emergence of anemia during pregnancy in a case of mitochondrial myopathy, lactic acidosis, and sideroblastic anemia 2 with compound heterozygous YARS2 pathogenic variantsAmerican Journal of Medical Genetics Part A, 2022
- Cardiomyopathy in children with mitochondrial disease: Prognosis and genetic backgroundInternational Journal of Cardiology, 2019
- Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial MyopathyJAMA Neurology, 2017
- A novel homozygous YARS2 mutation causes severe myopathy, lactic acidosis, and sideroblastic anemia 2Journal of Human Genetics, 2014
- A Novel Homozygous YARS2 Mutation in Two Italian Siblings and a Review of Literature2014
- A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutationsAmerican Journal of Medical Genetics Part A, 2013
- A novel mutation in YARS2 causes myopathy with lactic acidosis and sideroblastic anemiaHuman Mutation, 2012
- Mutation of the Mitochondrial Tyrosyl-tRNA Synthetase Gene, YARS2, Causes Myopathy, Lactic Acidosis, and Sideroblastic Anemia—MLASA SyndromeThe American Journal of Human Genetics, 2010
- Toward the Full Set of Human Mitochondrial Aminoacyl-tRNA Synthetases: Characterization of AspRS and TyrRSBiochemistry, 2005
- Cardiomyopathy in children with mitochondrial disease Clinical course and cardiological findingsEuropean Heart Journal, 2003